Title : Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis.

Pub. Date : 2019 Oct

PMID : 31357056






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In this trial, LF associated mortality is reduced for patients with elevated aspartate aminotransferase (AST) when treated with ribavirin (OR 0.41, 95% CI 0.23-0.73), while mortality is higher for patients without elevated AST (OR 2.37, 95% CI 1.07-5.25). Ribavirin solute carrier family 17 member 5 Homo sapiens
2 In this trial, LF associated mortality is reduced for patients with elevated aspartate aminotransferase (AST) when treated with ribavirin (OR 0.41, 95% CI 0.23-0.73), while mortality is higher for patients without elevated AST (OR 2.37, 95% CI 1.07-5.25). Ribavirin solute carrier family 17 member 5 Homo sapiens
3 In this trial, LF associated mortality is reduced for patients with elevated aspartate aminotransferase (AST) when treated with ribavirin (OR 0.41, 95% CI 0.23-0.73), while mortality is higher for patients without elevated AST (OR 2.37, 95% CI 1.07-5.25). Ribavirin solute carrier family 17 member 5 Homo sapiens